BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181 AND Prognosis
5 results:

  • 1. CSNK1D-mediated phosphorylation of hnrnpa2b1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m
    Qi F; Shen W; Wei X; Cheng Y; Xu F; Zheng Y; Li L; Qin C; Li X
    Cell Mol Life Sci; 2023 May; 80(6):156. PubMed ID: 37208565
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Identification and validation of hub genes in prostate cancer progression based on weighted gene co-expression network analysis].
    Zhang H; Chen N; Wang X; Gao B; Ling M; Chen G; Wu Z; Li Y; Zhong W; Pan B
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1631-1640. PubMed ID: 34916188
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characterization of the m6A-Associated Tumor Immune Microenvironment in prostate cancer to Aid Immunotherapy.
    Liu Z; Zhong J; Zeng J; Duan X; Lu J; Sun X; Liu Q; Liang Y; Lin Z; Zhong W; Wu W; Cai C; Zeng G
    Front Immunol; 2021; 12():735170. PubMed ID: 34531875
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
    Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
    Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis.
    Cheng Y; Li L; Qin Z; Li X; Qi F
    J Cell Mol Med; 2020 Jul; 24(14):8006-8017. PubMed ID: 32485038
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.